Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: COVID-19

Posted on April 11, 2021April 11, 2021

COVID-19: Protection against reinfection may last only for months

The first serosurvey was carried out in August-September 2020 and the six-month follow-up was carried out in end-January to February 2021. Widespread asymptomatic infection by mid-September when the daily cases…

Continue Reading
Posted on April 10, 2021

India will add four million more cases by May 1, says Giridhara Babu

The increase in daily cases has been very steep — from over 12,200 cases on March 1 to over 1,26,000 on April 7. The doubling time has reduced from 504…

Continue Reading
Posted on April 9, 2021

180 deaths following COVID-19 vaccination reported in India

In all, 492 severe and serious AEFI have been classified by the AEFI Secretariat of the immunisation technical support unit (ITSU) at the Health Ministry. Classification has been completed for…

Continue Reading
Posted on April 5, 2021April 5, 2021

Health Ministry reveals the names of SEC members for vaccine approval

Names of the ten members Dr. Varsha Gupta, Professor, Department of Microbiology, Government Medical College Hospital, Chandigarh; 2) Dr. Archana Thakur, Medical Director, Professor and HOD (Microbiology), G.B. Pant Hospital,…

Continue Reading
Posted on April 3, 2021April 4, 2021

What is driving the second wave in India?

The rate of increase in cases in India during March has been faster than at any other time during the pandemic, which is also reflected in the modelling studies by…

Continue Reading
Posted on April 1, 2021April 1, 2021

SEC allows Bharat Biotech to unblind all participants above 45 years

The Subject Expert Committee (SEC) has permitted Bharat Biotech to unblind all phase-3 trial participants above 45 years and offer the vaccine to those who received a placebo. The reason: vaccines (including Covaxin) are already available under the immunisation programme, and therefore all the eligible age groups should be unblinded for vaccination.

Continue Reading
Posted on April 1, 2021

Will intranasal vaccines confer sterilising immunity?

Developed by Washington University School of Medicine in St. Louis, the vaccine has been licensed to Bharat Biotech to carry out human clinical trials, manufacture the vaccine and distribute them…

Continue Reading
Posted on March 26, 2021March 26, 2021

Achieving vaccine equity by making comorbidities redundant for those above 45 years

By following the U.K. model of vaccinating people based on age bands rather than focussing on comorbidities, millions of people would become eligible to receive the vaccine and be fully…

Continue Reading

Posts navigation

Page 1 Page 2 … Page 33 Next Page
Follow Science Chronicle on WordPress.com

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 10,781 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • COVID-19: Protection against reinfection may last only for months April 11, 2021
  • India will add four million more cases by May 1, says Giridhara Babu April 10, 2021
  • 180 deaths following COVID-19 vaccination reported in India April 9, 2021
  • Health Ministry reveals the names of SEC members for vaccine approval April 5, 2021
  • What is driving the second wave in India? April 3, 2021

Most Read Posts

  • 180 deaths following COVID-19 vaccination reported in India
  • IGIB: In vaccinated people, Covishield first dose is highly immunogenic if already infected
  • India will add four million more cases by May 1, says Giridhara Babu
  • No correlation between Ct values of PCR test and COVID-19 severity
  • COVID-19: Protection against reinfection may last only for months
  • Gilead to begin testing inhaled remdesivir for early-stage treatment
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 10,781 other followers

Archives

Cancel

 
Loading Comments...
Comment
    ×